NCT04116060

Brief Summary

An expanding number of studies suggest a therapeutic role for nitrate and nitrite, most notably in treatment and prevention of cardiovascular disease including ischemia-reperfusion injury and hypertension. The nutritional aspects of these cardioprotective effects are particularly intriguing since nitrate is abundant in our everyday diet. Nitrate improves vascular functions in old adults and improves ischemia reperfusion injury in experimental models. Whether dietary nitrate improves erectile dysfunction is not known and will be investigated in the present study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 4, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

February 17, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
Last Updated

January 25, 2021

Status Verified

January 1, 2021

Enrollment Period

1.3 years

First QC Date

October 3, 2019

Last Update Submit

January 20, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The changes of erectile function according to the international index of erectile function (IIEF5) score

    Erectile dysfunction improvement as measured by IIEF5 score (range 5-25)

    4 Weeks

Secondary Outcomes (2)

  • Change in oral microbiome

    4 Weeks

  • Change in cardiac diastolic function,

    4 weeks

Study Arms (2)

Nitrate

EXPERIMENTAL

Dietary nitrate dissolved in water (0,12 mmol sodium-nitrate/kgBW/day) Dietary Supplement: Dietary nitrate 200 ml tab water with 0,12 mmol/kgBW sodium-nitrate

Dietary Supplement: Dietary Nitrate

Control

PLACEBO COMPARATOR

Dietary sodium-chloride dissolved in water (0,12 mmol sodium-chloride/kgBW/day) Dietary Supplement: Dietary sodium-chloride 200 ml tab water with 0,12 mmol/kgBW sodium-chloride

Dietary Supplement: Control

Interventions

Dietary NitrateDIETARY_SUPPLEMENT

Oral dietary nitrate supplementation with (0,12 mmol/kgBW sodium-nitrate)

Nitrate
ControlDIETARY_SUPPLEMENT

Placebo Comparator: Dietary sodium-chloride dissolved in water (0,12 mmol sodium-chloride/kgBW/day)

Control

Eligibility Criteria

Age30 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with erectile Dysfunction (IIEF5: 8-21) PDE-5 Inhibitors Responder Aged 30-80 years

You may not qualify if:

  • Spinal cord disease
  • Insulin dependent Diabetes mellitus
  • Prostate cancer after operation, radiotherapy and hormone therapy
  • Treatment with NO-Donators or sGC-Activators
  • Chronic kidney disease (Stage IV-V)
  • Advanced liver dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Essen

Essen, North Rhine-Westphalia, 45122, Germany

RECRUITING

MeSH Terms

Conditions

Erectile Dysfunction

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Officials

  • Tienush Rassaf, Prof

    University Hospital, Essen

    STUDY DIRECTOR
  • Christos Rammos, MD

    University Hospital, Essen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christos Rammos, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double blinded and randomised
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Parallel Assignment to intervention vs. control
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Principal Investigator

Study Record Dates

First Submitted

October 3, 2019

First Posted

October 4, 2019

Study Start

February 17, 2020

Primary Completion

June 1, 2021

Study Completion

August 1, 2021

Last Updated

January 25, 2021

Record last verified: 2021-01

Locations